Dr. Samuel Riley, an infectious‑disease specialist with the U.S. Agency for International Development (USAID), described his recent experience treating a cohort of Ebola patients under the age of five in a remote clinic in the Democratic Republic of Congo as “unprecedented.” The children, many of whom were under two years old, presented with severe dehydration, hemorrhagic symptoms, and a rapid progression of the disease, challenging conventional treatment protocols that are typically designed for adults. Dr. Riley and his team improvised pediatric dosing regimens for experimental antiviral drugs and employed novel rehydration techniques using oral rehydration salts mixed with locally sourced fruit juices to improve palatability. The effort, coordinated with the World Health Organization and local health ministries, has already yielded a 30 % survival rate among the youngest cohort, a significant improvement over previous outbreaks. The doctor urges the global health community to prioritize pediatric formulations in future Ebola response kits.
On top of everything as it happens